New salmeterol/fluticasone MDI extends choice in asthma prescribing

Aloflute (salmeterol/fluticasone) metered dose inhaler is licensed for the treatment of asthma where use of a combination product is appropriate.

by Lisa Lytle
Patients should not be initiated on Aloflute during an exacerbation, or if they have significantly worsening or acutely deteriorating asthma. | CAVALLINI JAMES/SCIENCE PHOTO LIBRARY
Patients should not be initiated on Aloflute during an exacerbation, or if they have significantly worsening or acutely deteriorating asthma. | CAVALLINI JAMES/SCIENCE PHOTO LIBRARY

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package